J Korean Neurosurg Soc.  1996 Mar;25(3):473-482.

A Comparative Study of PCNA(Proliferating Cell Nuclear Antigen) and AgNORs(Argyrophilic Nucleolar Organizer Regions) in Malignancy of Brain Tumors

Affiliations
  • 1Department of Neurosugery, College of Medicine, Chungnam National University, Taejon, Korea.

Abstract

The authors studied the expression of proliferating cell nuclear antigen (PCNA) and the number of argyrophilic nucleolar organizer regions (AgNORs) in 94 cases of various brain tumors and in 5 cases of normal brains. PCN was recognized immunohistochemically in paraffin sections by the monoclonal antibody PC-10. AgNORs could be demonstrated using the silver impregnation method. The PCNA index was not significantly different from the histological grading of glioma(glioblastoma multiforme: 41.40+/-29.14%, anaplastic astrocytoma: 35.00+/-41.02%, and low grade astrocytoma: 22.37+/-30.85%) and there was a wide range of staining even in the same tissue section. However, the AgNORs count per cell correlated well with the pathologic grading of glioma (glioblastoma multiforme : 3.19+/-0.71, anaplastic astrocytoma : 2.06+/-0.16, and low grade astrocytoma : 1.27+/-0.29) with statistical significance. In meningiomas, AgNORs were useful to differentiate benign meningiomas(1.25+/-0.19) and malignant meningiomas(1.78+/-0.35) The authors suggest that the AgNORs count is a faster, less expensive, and a more predictive method in the malignancy of brain tumors than the PCNA immunochemistry expression.

Keyword

PCNA(Proliferating Cell Nuclear Antigen); AgNORs(Argyrophilic Necleolar Organizer Regions); Normal

MeSH Terms

Astrocytoma
Brain Neoplasms*
Brain*
Glioma
Immunochemistry
Meningioma
Nucleolus Organizer Region*
Paraffin
Pregnenolone Carbonitrile
Proliferating Cell Nuclear Antigen
Silver
Paraffin
Pregnenolone Carbonitrile
Proliferating Cell Nuclear Antigen
Silver
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr